Preclinical Contract Research Organization (CRO)
Numira Biosciences is a preclinical contract research organization (CRO) that combines innovative tools and technologies to provide unique solutions to a wide variety of preclinical drug discovery efforts.
Our imaging technology and histology services are your comprehensive outsourcing solutions for disease research, drug discovery, and preclinical studies. Our therapeutic areas such as CNS, bone, pulmonary, oncology, and inflammation provide extensive value for many researchers. Utilizing our patented imaging reagents, and powerful 3D visualization tools, we provide you with images, metrics, and analyses that will allow definitive answers much more rapidly and accurately than ever before, saving your team valuable time and resources. We deliver a high-level of client support with customized study designs, frequent study updates and on-time study performance.
Explore our website and see how Numira is the perfect partner in your drug discovery endeavors!
Events and News
We are currently in the process of updating our website with our latest offerings. Please contact us at
to inquire about your customized development project.
April 30, 2013
Numira is pleased to announce our new service, AltaPortal, which allows our customers to manage projects and explore their datasets, media, and documents.Â AltaPortal is hosted in Microsoft's Azure cloud in order to guarantee fast, secure access to all of your preclinical data.
April 1, 2013
Numira Biosciences will be presenting at the American Association for Cancer Research (AACR) conference in Washington D.C., April 6-10. Numira will be presenting the following posters - Tumor vasculature imaging using AltaBlu Primeâ„¢ and Oncology 3D Cell Screening.
March 7, 2013
Numira Biosciences will be presenting at the Society of Toxicology (SOT) conference in San Antonio, March 10-14 at booth 1050.
October 29, 2012
Numira Biosciences and Lovelace Respiratory Institute sign cross marketing agreement. Click here for additional information.